NHS Greater Glasgow and Clyde — CureCurrent

How to interpret these research links

Connected source records

The exact organization name NHS Greater Glasgow and Clyde appears in 96 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials96

Recruiting shown7

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Glasgow Low-dose CT and AI-based Diagnostics to Case Find Lung Cancer and Other Cardio-respiratory Long-term Conditions - Feasibility StudyNCT07372508 · lead sponsor · 2026-05-26

Strategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency DepartmentNCT07391280 · lead sponsor · 2026-05-25

Combination of Biologic and Anti-obesity Therapies in Psoriatic ArthritisNCT07443956 · lead sponsor · 2026-03-09

Neurofeedback for Nociplastic Pain in Rheumatoid Arthritis (NECTAR)NCT06240299 · lead sponsor · 2024-06-24

The Gut-Lung Axis and Respiratory Illness in ChildrenNCT06271213 · lead sponsor · 2024-02-04

7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid ArthritisNCT05697159 · lead sponsor · 2023-08-22

Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"NCT05919342 · lead sponsor · 2022-12-22

Behavioural Activation and Severe Learning DisabilitiesNCT06851741 · lead sponsor · 2025-03-04

NOT_YET_RECRUITING

Biomarkers for the Assessment of Congestion in Patients With Ambulatory and Hospitalised Heart FailureNCT06459999 · lead sponsor · 2024-06-01

Correlation of Non-invasive CPM Wearable Device With Measures of Congestion in Heart Failure in ExerciseNCT06393842 · lead sponsor · 2024-03-22

Adiposity and Immunometabolism in SepsisNCT06307509 · lead sponsor · 2024-03-01

Radiograph Accelerated Detection and Identification of Cancer in the LungNCT06044454 · lead sponsor · 2023-12-04

ACTIVE_NOT_RECRUITING

Study to Determine the Feasibility of Using an At-home Foot Temperature Monitoring Device (Thermidas)NCT06032221 · lead sponsor · 2023-07-14

DYNAMIC AI: Digital Innovation With Remote Management and Predictive Modelling to Integrate COPD Care With Artificial Intelligence-based Insights: An Acceptability, Feasibility and Safety StudyNCT05914220 · lead sponsor · 2023-04-01

CharacterisatiON of carDiac funCTion in Intensive Care Unit Survivors of Sepsis.NCT05633290 · lead sponsor · 2023-03-01

Biomarkers in Patients With Suspected HFpEFNCT06101693 · lead sponsor · 2023-02-02

Targeted Assessment in High-Risk paTients With dIAbetes to ideNtify Undiagnosed Heart FailureNCT05705869 · lead sponsor · 2022-12-22

ACTIVE_NOT_RECRUITING

Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart FailureNCT05419115 · lead sponsor · 2022-11-17

Experimental Medicine Studies of the Brain in Patients With Rheumatoid Arthritis REALISENCT05090124 · lead sponsor · 2022-11-04

OPTIMA-BP: Empowering PaTients in MAnaging Blood PressureNCT05575453 · lead sponsor · 2022-09-29

Multiple Sclerosis Outcome Determination Evaluating Real Differences After TimENCT05446285 · lead sponsor · 2022-02-07

A Reminder App for Supporting Adherence to Treatment Goals in Parkinson's DiseaseNCT05106985 · lead sponsor · 2022-01-20

Probing the Rheumatoid Arthritis Brain to Elucidate Central Pain PathwaysNCT05693532 · lead sponsor · 2021-11-12

Quantifying Congestion by UltrasoundNCT05090137 · lead sponsor · 2021-11-01

Correlation of the Non-invasive Cardiopulmonary Management (CPM) Wearable Device With Measures of Congestion in Heart FailureNCT05026034 · lead sponsor · 2021-09-23

Exploiting Leading Edge 7T MRI Brain Imaging to Decipher Olumiant's Mode of Analgesic Action in Rheumatoid ArthritisNCT05112120 · lead sponsor · 2021-07-21

DAPAgliflozin Versus Thiazide Diuretic in Patients With Heart Failure and Diuretic RESISTanceNCT04860011 · lead sponsor · 2021-04-27

Implementation of Digital CBT for Insomnia in First Episode PsychosisNCT05050201 · lead sponsor · 2021-04-20

Lung Cancer Patients' Attitudes to a Second Course of RadiotherapyNCT04813068 · lead sponsor · 2021-04-16

Optimising a Digital Diagnostic Pathway for Heart Failure in the CommunityNCT04724200 · lead sponsor · 2021-01-05

Augmented Reality (AR): The Future of "Patient Information LeafletsNCT04619030 · lead sponsor · 2020-11-30

RELieving Increasing oEdema Due to Heart FailureNCT04142788 · lead sponsor · 2020-08-26

COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX)NCT04409847 · lead sponsor · 2020-06-01

Effect of Metacognitive Therapy on Negative Symptoms: a Case SeriesNCT03999112 · lead sponsor · 2020-01-22

Benralizumab Exacerbation StudyNCT04102800 · lead sponsor · 2019-09-30

Psychological Therapy for Dissociation, Trauma and Voices: A Single Case Experimental DesignNCT04127526 · lead sponsor · 2019-09-11

Weight Loss for Uncontrolled Asthma Associated With Elevated BMINCT03858608 · lead sponsor · 2019-08-12

BEAT-IT: Behavioural Activation and Severe Learning DisabilitiesNCT04744259 · lead sponsor · 2019-02-18

Inflammation Following Mepolizumab and Oral Corticosteroids in AsthmaNCT03610685 · lead sponsor · 2018-10-19

RECEIVER: Digital Service Model for Chronic Obstructive Pulmonary Disease (COPD)NCT04240353 · lead sponsor · 2018-08-01

The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MINCT03552575 · lead sponsor · 2018-07-01

Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic EffectsNCT03485092 · lead sponsor · 2018-03-16

Web-based Exercise for South Asian People With Type 2 DiabetesNCT03203278 · lead sponsor · 2017-11-06

Obesity and Type 2 Diabetes - Raising the Issue of Weight Management in Primary CareNCT03360058 · lead sponsor · 2017-10-07

EDIT Management Feasibility TrialNCT03319186 · lead sponsor · 2017-08-28

Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)NCT02758587 · lead sponsor · 2017-07-04

Audio Technology To Detect Lung Cancer EarlierNCT03566862 · lead sponsor · 2017-05-16

Pulmonary Rehabilitation for Uncontrolled Asthma Associated With Elevated BMINCT03630432 · lead sponsor · 2017-05-11

Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in HypertensionNCT03354897 · lead sponsor · 2017-04-05

Endothelial Effects of VEGF Inhibition In Vivo in ManNCT03557190 · lead sponsor · 2016-12-01

Effect of Active-Passive Trainer Cycling on Multiple SclerosisNCT02737904 · lead sponsor · 2016-08-01

Manometry vs Clinical Assessment in the Detection of Trapped Lung in Patients With Suspected Pleural MalignancyNCT02805062 · lead sponsor · 2016-06-01

Dietary Polyphenols and Glycation in Renal InsufficiencyNCT02524938 · lead sponsor · 2016-06-01

BEYOND Weight Loss Maintenance StudyNCT02683798 · lead sponsor · 2016-04-12

Inhibition of Co-Stimulation in Rheumatoid ArthritisNCT02652273 · lead sponsor · 2016-01-01

Impact of Immune Challenge on Triple Network Connectivity in HumansNCT02653235 · lead sponsor · 2016-01-01

Taxane Chemotherapy and Nail Toxicity in Women With Breast Cancer; Stage Two: Evaluation of InterventionsNCT02583204 · lead sponsor · 2015-10-01

Feasibility of Magnetic Resonance Spectroscopy in Lung CancerNCT02497586 · lead sponsor · 2015-08-01

BEYOND Weight Loss StudyNCT02340793 · lead sponsor · 2015-01-01

Mindfulness-based Stress Reduction in Multiple SclerosisNCT02136485 · lead sponsor · 2014-06-02

Drugs studied in this sponsor's trials

25 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing NHS Greater Glasgow and Clyde as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

placebo8

metformin2

abatacept1

adalimumab1

allopurinol1

ambrisentan1

atorvastatin1

azithromycin1

placebo RxCUI 8375 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 8 trials metformin RxCUI 6809 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials abatacept RxCUI 614391 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial adalimumab RxCUI 327361 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial allopurinol RxCUI 519 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial ambrisentan RxCUI 358274 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial atorvastatin RxCUI 83367 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial azithromycin RxCUI 18631 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial benralizumab RxCUI 1989100 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial bisoprolol RxCUI 19484 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial bosentan RxCUI 75207 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial dapagliflozin 10 MG Oral Tablet RxCUI 1488569 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial defactinib RxCUI 2714502 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial empagliflozin 10 MG RxCUI 1545654 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ferric derisomaltose RxCUI 2274394 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial ixekizumab RxCUI 1745099 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial metolazone Oral Tablet RxCUI 372888 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial Olumiant RxCUI 2047242 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial patiromer RxCUI 1716203 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial pembrolizumab RxCUI 1547545 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial placebo Oral Tablet RxCUI 375221 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial prednisolone RxCUI 8638 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial sacubitril / valsartan RxCUI 1656339 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial tirzepatide RxCUI 2601723 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial

Sponsor roles

lead sponsor69

collaborator27

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.